DK1140200T3 - Anthraquinonbaserede antikræftmidler - Google Patents
Anthraquinonbaserede antikræftmidlerInfo
- Publication number
- DK1140200T3 DK1140200T3 DK99959561T DK99959561T DK1140200T3 DK 1140200 T3 DK1140200 T3 DK 1140200T3 DK 99959561 T DK99959561 T DK 99959561T DK 99959561 T DK99959561 T DK 99959561T DK 1140200 T3 DK1140200 T3 DK 1140200T3
- Authority
- DK
- Denmark
- Prior art keywords
- anthraquinone
- anticancer agents
- based anticancer
- formula
- tertiary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9828670.1A GB9828670D0 (en) | 1998-12-24 | 1998-12-24 | Anthraquinone anticancer drugs |
| PCT/GB1999/004158 WO2000038734A1 (fr) | 1998-12-24 | 1999-12-09 | Medicaments anticancereux a base d'anthraquinone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1140200T3 true DK1140200T3 (da) | 2003-03-10 |
Family
ID=10845050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99959561T DK1140200T3 (da) | 1998-12-24 | 1999-12-09 | Anthraquinonbaserede antikræftmidler |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6465522B1 (fr) |
| EP (1) | EP1140200B1 (fr) |
| JP (1) | JP2002533418A (fr) |
| AT (1) | ATE227588T1 (fr) |
| AU (1) | AU759549B2 (fr) |
| CA (1) | CA2356399A1 (fr) |
| DE (1) | DE69903974T2 (fr) |
| DK (1) | DK1140200T3 (fr) |
| ES (1) | ES2188273T3 (fr) |
| GB (1) | GB9828670D0 (fr) |
| PT (1) | PT1140200E (fr) |
| WO (1) | WO2000038734A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6800615B2 (en) | 2002-04-15 | 2004-10-05 | Board Of Trustees Of Michigan State University | Antihelminthic anthraquinones and method of use thereof |
| US20040236414A1 (en) * | 2003-05-23 | 2004-11-25 | Brar Balbir S. | Devices and methods for treatment of stenotic regions |
| US20070117784A1 (en) * | 2005-03-04 | 2007-05-24 | Novacea, Inc. | Treatment of hyperproliferative diseases with anthraquinones |
| US20070208085A1 (en) * | 2006-01-17 | 2007-09-06 | Somanta Limited | Potent cytotoxicity and inhibition of pan-cell cycle progression by an alkylating anthraquinone |
| US8420861B2 (en) * | 2007-10-16 | 2013-04-16 | D. Richard Ishmael | Anti-tumor compounds derived from 1,4,5,8-tetrachloroanthraquinone |
| WO2013028543A1 (fr) | 2011-08-19 | 2013-02-28 | Emory University | Agoniste de bax, compositions et procédés associés |
| US9980936B2 (en) | 2014-05-05 | 2018-05-29 | Emory University | BH4 antagonists and methods related thereto |
| CN108395379A (zh) * | 2018-03-30 | 2018-08-14 | 南京医科大学康达学院 | 一种米托蒽醌的半合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES472508A1 (es) * | 1977-08-15 | 1979-10-16 | American Cyanamid Co | Procedimiento para la obtencion de derivados de antraquinona |
| CS231079B1 (cs) * | 1982-07-16 | 1984-09-17 | Libuse Havlickova | Způsob přípravy farmakologicky účinných derivátů 1,4-diaminoantrachinonu |
| JPS60199863A (ja) * | 1984-03-23 | 1985-10-09 | Dai Ichi Seiyaku Co Ltd | アミノアンスラセン誘導体 |
| EP0182135A3 (fr) * | 1984-11-19 | 1987-08-05 | American Cyanamid Company | Aminoanthraquinones bis-N-substituées |
| GB8923075D0 (en) * | 1989-10-13 | 1989-11-29 | Patterson Laurence H | Anti-cancer compounds |
| JPH07138212A (ja) * | 1993-11-16 | 1995-05-30 | Japan Tobacco Inc | アミノアントラキノン化合物及びそれを含有してなる抗腫瘍剤 |
| ATE243520T1 (de) | 1998-02-12 | 2003-07-15 | Univ Montfort | Durch hydroxylierung aktivierte wirkstofffreigabe |
-
1998
- 1998-12-24 GB GBGB9828670.1A patent/GB9828670D0/en not_active Ceased
-
1999
- 1999-12-09 DE DE69903974T patent/DE69903974T2/de not_active Expired - Fee Related
- 1999-12-09 WO PCT/GB1999/004158 patent/WO2000038734A1/fr active IP Right Grant
- 1999-12-09 AT AT99959561T patent/ATE227588T1/de not_active IP Right Cessation
- 1999-12-09 US US09/868,956 patent/US6465522B1/en not_active Expired - Fee Related
- 1999-12-09 CA CA002356399A patent/CA2356399A1/fr not_active Abandoned
- 1999-12-09 EP EP99959561A patent/EP1140200B1/fr not_active Expired - Lifetime
- 1999-12-09 DK DK99959561T patent/DK1140200T3/da active
- 1999-12-09 JP JP2000590685A patent/JP2002533418A/ja active Pending
- 1999-12-09 ES ES99959561T patent/ES2188273T3/es not_active Expired - Lifetime
- 1999-12-09 PT PT99959561T patent/PT1140200E/pt unknown
- 1999-12-09 AU AU16701/00A patent/AU759549B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE227588T1 (de) | 2002-11-15 |
| AU1670100A (en) | 2000-07-31 |
| EP1140200B1 (fr) | 2002-11-13 |
| CA2356399A1 (fr) | 2000-07-06 |
| WO2000038734A1 (fr) | 2000-07-06 |
| PT1140200E (pt) | 2003-03-31 |
| EP1140200A1 (fr) | 2001-10-10 |
| DE69903974D1 (de) | 2002-12-19 |
| ES2188273T3 (es) | 2003-06-16 |
| GB9828670D0 (en) | 1999-02-17 |
| DE69903974T2 (de) | 2003-09-04 |
| JP2002533418A (ja) | 2002-10-08 |
| AU759549B2 (en) | 2003-04-17 |
| US6465522B1 (en) | 2002-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200102800T2 (tr) | Yeni bileşikler. | |
| FI903331A0 (fi) | Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister. | |
| DE69426205T2 (de) | Gastrin-und cck-rezeptorligande | |
| AR006390A1 (es) | Derivados de lactama | |
| ES2043625T3 (es) | Derivados de acido ariloxicarboxilico, su preparacion y empleo. | |
| ATE18902T1 (de) | Aminosaeurederivate und ihre therapeutischen verwendungen. | |
| DK0700380T3 (da) | N-Alkylthiopolyaminderivater som radioprotektive midler | |
| PE20020144A1 (es) | Derivados de pleuromutilinas como agentes antibacterianos | |
| DK1140200T3 (da) | Anthraquinonbaserede antikræftmidler | |
| ES2064729T3 (es) | Complejos de rutenio (iii) como agentes antineoplasticos. | |
| IL141830A0 (en) | Chemiluminescent 1,2-dioxetane | |
| BR0115996A (pt) | Sulfamidotienopirimidinas | |
| BR9902084A (pt) | Heterociclos. | |
| ATE78830T1 (de) | Lactamderivate, deren herstellung und deren benutzung als hypotensive mittel. | |
| DK0589322T3 (da) | 5-Oxo-dibenzo a,d cyclohepta-1,4-diener samt deres anvendelse som retrovirale midler. | |
| PE20000734A1 (es) | Compuestos heterociclicos derivados de furopiridina y su uso terapeutico | |
| TR199902873T2 (xx) | Miyozun mod�lasyonu i�in 17�-aliloksi(tiyo)alkil-androstan t�revleri. | |
| TR200102501T2 (tr) | Antiviral nükleozid analoglar. | |
| DE69940551D1 (de) | Mercaptane und disulfide | |
| BR0009453A (pt) | Processo para a preparação de um composto | |
| ATE223462T1 (de) | Naphthalenehydrazamimide und perylenhydrazamimide | |
| ES2066187T3 (es) | Compuestos de fosforo. | |
| AR036810A1 (es) | Un tinte de complejo de metal 1:2, sus composiciones, su produccion y su uso | |
| DK0736009T3 (da) | N-oxider af 4-arylpiperaziner og 4-arylpiperidiner som antipsykotiske medikamenter | |
| TR200002755T2 (tr) | Aracı hazırlamak için süreç. |